Overview

Efficacy and Safety of FTY720 for Acute Stroke

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Stroke is one of the main severe disease of public health importance. Increasing evidence suggests that inflammatory mechanisms plays a significant role in stroke. So, immune targets are supposed to be an effective one. The sphingosine-1-phosphate receptor regulator Fingolimod(FTY720)is an effective immunology modulator which has been widely used in autoimmune disease and has been testified effective on stoke animal models.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University General Hospital
Treatments:
Fingolimod Hydrochloride